Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a study
Published Online: 2018-08-?
Journal: The Lancet Infectious Diseases•Publisher: Elsevier BV
Authors: Alejandro Llanos-Cuentas•Annie N Cowell•Caroline L Ng•David A Fidock•Elizabeth A Winzeler•Felix D Rozenberg•Jade Bath•Juan-Carlos Hinojosa•Jörg J Möhrle•Margaret A Phillips•Maria Rosario•Mark Baker•Martin Casapia•Nada Araeipour•Nathalie Gobeau•Nicola Kerr•Nicole Andenmatten•Raúl Chuquiyauri•Rob Hooft van Huijsduijnen•Robert H Arch•Stephan Duparc•Stephen Toovey•Thomas Rückle
